Erscheint 6 Ausgaben pro Jahr
ISSN Druckformat: 1040-8401
ISSN Online: 2162-6472
Indexed in
A CCL2-Based Fusokine as a Novel Biopharmaceutical for the Treatment of CCR2-Driven Autoimmune Diseases
ABSTRAKT
Autoimmune diseases represent one of the most challenging clinical entities with unmet medical needs, so the continued development of novel therapeutics is well justified. Most autoimmune diseases are marked by the infiltration of lymphomyeloid cells in target tissues, leading to inflammation and tissue damage. This process is guided by chemokines that act as signaling bridges amidst a complex network of immune cells. For example, monocytes are believed to be the primary cell type responsible for pathology initiation and tissue damage, while T lymphocytes are thought to orchestrate the process by secreting more cytokines/chemokines to amplify leukocyte homing. Many studies have addressed the molecular basis of monocyte recruitment in different autoimmune diseases, and the conclusions pointed to a major role played by monocyte chemoattractant protein 1 (MCP-1), also known as CC chemokine ligand 2 (CCL2), and its cell-surface receptor, CC chemokine receptor (CCR) 2. These findings suggest that by interfering with CCL2 or its receptor, it is possible to inhibit the progression of CCR2-dependent diseases. Therefore, future therapy design targeting a maladapted immune response could target chemokine receptors starting with the CCL2-CCR2 axis.
-
Hsieh Jeremy, Williams Patrick, Rafei Moutih, Birman Elena, Cuerquis Jessica, Yuan Shala, Wu JianHui, Galipeau Jacques, Inducible IL10+ Suppressor B Cells Inhibit CNS Inflammation and T Helper 17 Polarization, Molecular Therapy, 20, 9, 2012. Crossref
-
Bauer D., Redmon N., Mazzio E., Taka E., Reuben J.S., Day A., Sadrud-Din S., Flores-Rozas H., Soliman K.F.A., Darling-Reed S., Diallyl disulfide inhibits TNFα induced CCL2 release through MAPK/ERK and NF-Kappa-B signaling, Cytokine, 75, 1, 2015. Crossref
-
Carson William F., Salter-Green Sarah E., Scola Melissa M., Joshi Amrita, Gallagher Katherine A., Kunkel Steven L., Enhancement of macrophage inflammatory responses by CCL2 is correlated with increased miR-9 expression and downregulation of the ERK1/2 phosphatase Dusp6, Cellular Immunology, 314, 2017. Crossref
-
Manli Wang, Hua Qiao, Effect of miR-506-3p on Proliferation and Apoptosis of Airway Smooth Muscle Cells in Asthmatic Mice by Regulating CCL2 Gene Expression and Mediating TLR4/NF-κB Signaling Pathway Activation, Molecular Biotechnology, 63, 5, 2021. Crossref
-
Rogler Gerhard, New Therapeutic Avenues for Treatment of Fibrosis: Can We Learn from Other Diseases?, Digestive Diseases, 32, Suppl. 1, 2014. Crossref